|
1
|
Linet MS, Ries LA, Smith MA, Tarone RE and
Devesa SS: Cancer surveillance series: Recent trends in childhood
cancer incidence and mortality in the United States. J Natl Cancer
Inst. 91:1051–1058. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pui C-H: Acute lymphoblastic leukemia in
children. Curr Opin Oncol. 12:3–12. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
le Viseur C, Hotfilder M, Bomken S, Wilson
K, Röttgers S, Schrauder A, Rosemann A, Irving J, Stam RW, Shultz
LD, et al: In childhood acute lymphoblastic leukemia, blasts at
different stages of immunophenotypic maturation have stem cell
properties. Cancer Cell. 14:47–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Belson M, Kingsley B and Holmes A: Risk
factors for acute leukemia in children: A review. Environ Health
Perspect. 115:138–145. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kelly PN, Dakic A, Adams JM, Nutt SL and
Strasser A: Tumor growth need not be driven by rare cancer stem
cells. Science. 317:3372007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kennedy JA, Barabé F, Poeppl AG, Wang JC
and Dick JE: Comment on ‘Tumor growth need not be driven by rare
cancer stem cells’. Science. 318:17222007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pui C-H, Relling MV and Downing JR: Acute
lymphoblastic leukemia. N Engl J Med. 350:1535–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ross DD: Novel mechanisms of drug
resistance in leukemia. Leukemia. 14:467–473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swerts K, De Moerloose B, Dhooge C,
Laureys G, Benoit Y and Philippé J: Prognostic significance of
multidrug resistance-related proteins in childhood acute
lymphoblastic leukaemia. Eur J Cancer. 42:295–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanner SM, Austin JL, Leone G, Rush LJ,
Plass C, Heinonen K, Mrózek K, Sill H, Knuutila S, Kolitz JE, et
al: BAALC, the human member of a novel mammalian neuroectoderm gene
lineage, is implicated in hematopoiesis and acute leukemia. Proc
Natl Acad Sci USA. 98:13901–13906. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baldus CD, Tanner SM, Kusewitt DF,
Liyanarachchi S, Choi C, Caligiuri MA, Bloomfield CD and de la
Chapelle A: BAALC, a novel marker of human hematopoietic progenitor
cells. Exp Hematol. 31:1051–1056. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo X, Shi P, Chen F, Zha J, Liu B, Li R,
Dong H, Zheng H and Xu B: Low MDR1 and BAALC expression identifies
a new subgroup of intermediate cytogenetic risk acute myeloid
leukemia with a favorable outcome. Blood Cells Mol Dis. 53:144–148.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Langer C, Radmacher MD, Ruppert AS,
Whitman SP, Paschka P, Mrózek K, Baldus CD, Vukosavljevic T, Liu
CG, Ross ME, et al: Cancer and Leukemia Group B (CALGB): High BAALC
expression associates with other molecular prognostic markers, poor
outcome and a distinct gene-expression signature in cytogenetically
normal patients younger than 60 years with acute myeloid leukemia:
A Cancer and Leukemia Group B (CALGB) study. Blood. 111:5371–5379.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kühnl A, Gökbuget N, Stroux A, Burmeister
T, Neumann M, Heesch S, Haferlach T, Hoelzer D, Hofmann WK, Thiel
E, et al: High BAALC expression predicts chemoresistance in adult
B-precursor acute lymphoblastic leukemia. Blood. 115:3737–3744.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leonard GD, Fojo T and Bates SE: The role
of ABC transporters in clinical practice. Oncologist. 8:411–424.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gillet J-P and Gottesman MM: Mechanisms of
multidrug resistance in cancer. Methods Mol Biol. 596:47–76. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marques DS, Sandrini JZ, Boyle RT, Marins
LF and Trindade GS: Relationships between multidrug resistance
(MDR) and stem cell markers in human chronic myeloid leukemia cell
lines. Leuk Res. 34:757–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rahgozar S, Moafi A, Abedi M,
Entezar-E-Ghaem M, Moshtaghian J, Ghaedi K, Esmaeili A and
Montazeri F: mRNA expression profile of multidrug-resistant genes
in acute lymphoblastic leukemia of children, a prognostic value for
ABCA3 and ABCA2. Cancer Biol Ther. 15:35–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abedi M, Rahgozar S, Moafi A, et al:
Evaluation of the expression profile of MDR1 gene and assessment of
its prognostic value in childhood ALL. Sci J Iran Blood Transfus
Organ. 10:326–334. 2014.
|
|
20
|
Baldus CD, Tanner SM, Ruppert AS, Whitman
SP, Archer KJ, Marcucci G, Caligiuri MA, Carroll AJ, Vardiman JW,
Powell BL, et al: BAALC expression predicts clinical outcome of de
novo acute myeloid leukemia patients with normal cytogenetics: A
Cancer and Leukemia Group B Study. Blood. 102:1613–1618. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baldus CD, Martus P, Burmeister T,
Schwartz S, Gökbuget N, Bloomfield CD, Hoelzer D, Thiel E and
Hofmann WK: Low ERG and BAALC expression identifies a new subgroup
of adult acute T-lymphoblastic leukemia with a highly favorable
outcome. J Clin Oncol. 25:3739–3745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gregory TK, Wald D, Chen Y, Vermaat JM,
Xiong Y and Tse W: Molecular prognostic markers for adult acute
myeloid leukemia with normal cytogenetics. J Hematol Oncol.
2:232009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weber S, Alpermann T, Dicker F, Jeromin S,
Nadarajah N, Eder C, Fasan A, Kohlmann A, Meggendorfer M, Haferlach
C, et al: BAALC expression: A suitable marker for prognostic risk
stratification and detection of residual disease in cytogenetically
normal acute myeloid leukemia. Blood Cancer J. 4:e1732014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mizushima Y, Taki T, Shimada A, Yui Y,
Hiraumi Y, Matsubara H, Watanabe M, Watanabe K, Kamitsuji Y,
Hayashi Y, et al: Prognostic significance of the BAALC isoform
pattern and CEBPA mutations in pediatric acute myeloid leukemia
with normal karyotype: A study by the Japanese Childhood AML
Cooperative Study Group. Int J Hematol. 91:831–837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu B, Chen G, Shi P, Guo X, Xiao P, Wang W
and Zhou S: shRNA-Mediated BAALC knockdown affects proliferation
and apoptosis in human acute myeloid leukemia cells. Hematology.
17:35–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
